Evaluation of everolimus pneumonitis and clinical efficacy: a multi-institutional retrospective study

Evaluation of everolimus pneumonitis and clinical efficacy: a multi-institutional retrospective study - Evaluation of everolimus pneumonitis and clinical efficacy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032570

Enrollment

150

Registered

2018-05-14

Start date

2018-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HER2-negative advanced/metastatic breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. ER positive and/or PgR positive 2. HER2 negative 3. patient with administration of everolimus for more than 1 week

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
frequency of everolimus pneumonitis	—

Countries

Japan

Contacts

Public ContactTakeshi Kotake

Kyoto University Hospital Breast surgery

tkkotake@gmail.com0757513660

Outcome results